CCKP

New features, data, types of data and more

🧰CCKP Toolkit Tool Feature: phangorn

By |2026-02-13T17:36:03+00:00February 13, 2026|CCKP, Tools|

phangorn is an R package for phylogenetic reconstruction and analysis. It supports Maximum Likelihood, Maximum Parsimony, distance-based methods, and Hadamard conjugation, enabling researchers to [...]

Comments Off on 🧰CCKP Toolkit Tool Feature: phangorn

📈New Dataset: NR2F1 underlies persistence of residual disease in BRAF-mutant melanoma

By |2026-01-15T21:39:21+00:00January 15, 2026|CCKP, Data Features|

Targeted therapies for melanoma, like BRAF and MEK inhibitors, can shrink tumors but often fail to completely eliminate all cancer cells. A small group [...]

Comments Off on 📈New Dataset: NR2F1 underlies persistence of residual disease in BRAF-mutant melanoma

📈New Dataset: Pancreatic cancer xenograft tumor RNA sequencing and pathologic differentiation of matched human tumors

By |2025-12-08T17:46:48+00:00September 25, 2025|CCKP, Data Features|

From Brown et al. (https://pubmed.ncbi.nlm.nih.gov/38471099/), this dataset investigates the epithelial to mesenchymal transition (EMT) in pancreatic cancer. EMT is believed to correlate with metastatic [...]

Comments Off on 📈New Dataset: Pancreatic cancer xenograft tumor RNA sequencing and pathologic differentiation of matched human tumors

New Dataset: Window of opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma

By |2025-07-09T16:41:54+00:00July 23, 2025|CCKP, Data Features|

This dataset investigates the effectiveness of p53 reactivation in treating glioblastoma. They achieve this by treating multiple patients with differing levels of MDM2 inhibitor [...]

Comments Off on New Dataset: Window of opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma
Go to Top